Eight potential target genes of brazilin (PB) were analyzed using cBioportal to explore their genomic alterations across breast cancer studies. CCL2, MAP3K8, MMP14, PIK3CB, and CXCL3 were selected from KEGG pathway enrichment analysis. This evidence concerns the gene CCL2 and breast cancer.